Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer’s Bococizumab Discontinuation Increases Uncertainty For Other PCSK9s

Nov 02 2016

• By Jessica Merrill

Related Content

PCSK9 Mechanism Lends Confidence Ahead Of Outcomes Data

Mar 23 2015

Pfizer Assembling New Commercial Team For Move Into Dermatology

Oct 19 2016

Pfizer Dashes Hopes For A PCSK9 Pill

Aug 02 2016

Related Companies

Amgen, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Pfizer Inc.

Additional Topics

Research & Development BioPharmaceutical Cardiovascular

More from Cardiovascular

More from Therapeutic Category

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.